2021. In-silico Design of a Core Scaffold Pyrazolone Fused Heterocyclic Analogues as Dual Inhibitors Targeting Breast Cancer. Asian Journal of Pharmaceutical and Health Sciences. 11, 2 (Jun. 2021), 2468–2474. DOI:https://doi.org/10.5530/qsrddd17.